Publikationen, an denen er mitarbeitet María Pilar Civeira Murillo (20)

2014

  1. Characterization of the CD40L/Oncostatin M/Oncostatin M receptor axis as an antiviral and immunostimulatory system disrupted in chronic HCV infection

    Journal of Hepatology, Vol. 60, Núm. 3, pp. 482-489

  2. Dysregulation of interferon regulatory factors impairs the expression of immunostimulatory molecules in hepatitis C virus genotype 1-infected hepatocytes

    Gut, Vol. 63, Núm. 4, pp. 665-673

2008

  1. Monocyte-derived dendritic cells from HCV-infected patients transduced with an adenovirus expressing NS3 are functional when stimulated with the TLR3 ligand poly(I:C)

    Journal of Viral Hepatitis, Vol. 15, Núm. 11, pp. 782-789

2007

  1. Upregulation of indoleamine 2,3-dioxygenase in hepatitis C virus infection

    Journal of Virology, Vol. 81, Núm. 7, pp. 3662-3666

2006

  1. Recombinant Adenoviral Vectors Turn on the Type I Interferon System without Inhibition of Transgene Expression and Viral Replication

    Molecular Therapy, Vol. 14, Núm. 1, pp. 129-138

2005

  1. Hepatitis C virus infection of primary tupaia hepatocytes leads to selection of quasispecies variants, induction of interferon-stimulated genes and NF-κB nuclear translocation

    Journal of General Virology, Vol. 86, Núm. 11, pp. 3065-3074

2004

  1. IFN-α5 mediates stronger Tyk2-stat-dependent activation and higher expression of 2′,5′-oligoadenylate synthetase than IFN-α2 in liver cells

    Journal of Interferon and Cytokine Research, Vol. 24, Núm. 8, pp. 497-503

1999

  1. Immunogenicity of variable regions of hepatitis C virus proteins: Selection and modification of peptide epitopes to assess hepatitis C virus genotypes by ELISA

    Journal of General Virology, Vol. 80, Núm. 3, pp. 727-738

1998

  1. Transmission of hepatitis C virus infection to tree shrews

    Virology, Vol. 244, Núm. 2, pp. 513-520

1997

  1. Viremia after one month of interferon therapy predicts treatment outcome in patients with chronic hepatitis C

    Gastroenterology, Vol. 113, Núm. 5, pp. 1647-1653

1996

  1. Anticardiolipin antibodies in chronic hepatitis C: Implication of hepatitis C virus as the cause of the antiphospholipid syndrome

    Hepatology, Vol. 23, Núm. 2, pp. 199-204

1995

  1. Interferon treatment of chronic hepatitis C: a randomised, controlled study of human lymphoblastoid alpha-interferon versus no therapy

    Lymphoblastoid alpha-interferon (Current Medical Literature Ltd), pp. 113 - 122

1994

  1. Prediction of sustained remission of chronic hepatitis C after a 12-month course of alfa interferon

    Journal of Hepatology, Vol. 21, Núm. 1, pp. 4-11

1993

  1. Detection of anti-hepatitis C virus antibodies by ELISA using synthetic peptides

    Journal of Hepatology, Vol. 18, Núm. 1, pp. 80-84

  2. Hepatic and extrahepatic HCV RNA strands in chronic hepatitis C: Different patterns of response to interferon treatment

    Hepatology, Vol. 18, Núm. 5, pp. 1050-1054

  3. Prediction of the response of chronic hepatitis C to interferon alfa: A statistical analysis of pretreatment variables

    Gut, Vol. 34, Núm. 12, pp. 1714-1717

  4. Ribavirin in the treatment of chronic hepatitis C unresponsive to alfa interferon

    Journal of Hepatology, Vol. 19, Núm. 3, pp. 408-412

1992

  1. Detection of hepatitis B virus DNA in serum by gene amplification in patients with chronic hepatitis B and in patients chronic hepatitis C

    Medicina clínica, Vol. 98, Núm. 2, pp. 49-52

  2. Detection of hepatitis C virus antibodies with new recombinant antigens: assessment in chronic liver diseases

    Journal of Hepatology, Vol. 15, Núm. 3, pp. 309-313

1990

  1. Virus herpes humano tipo 6 y síndrome de astenia crónica.

    Medicina clinica, Vol. 94, Núm. 19, pp. 721-724